Overview

Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

Status:
Terminated
Trial end date:
2019-09-25
Target enrollment:
Participant gender:
Summary
The study evaluated the efficacy, safety and pharmacokinetics of VAY736 in the treatment of patients with pemphigus vulagaris (PV).
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals